Reduction of raf kinase inhibitor protein expression by Bcr-Abl contributes to chronic myelogenous leukemia proliferation (Journal of Biological Chemistry (2010) 285, 9, (6585-6594))

Journal of Biological Chemistry

Volumn 285, Issue 9, 2010, Pages 6585-6594

  Takemura, Tomonari ^a   Nakamura, Satoki ^a   Yokota, Daisuke ^a   Hirano, Isao ^a   Ono, Takaaki ^a   Shigeno, Kazuyuki ^a   Fujisawa, Shinya ^b   Ohnishi, Kazunori ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HAMAMATSU MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ERRATUM; PRIORITY JOURNAL; RETRACTED ARTICLE; ARTICLE; CELL PROLIFERATION; CHRONIC MYELOID LEUKEMIA; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PHYSIOLOGY; STEM CELL; TUMOR CELL CULTURE;

BCR ABL PROTEIN; FORKHEAD TRANSCRIPTION FACTOR; FOXM1 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PROTEIN KINASE INHIBITOR;

CELL PROLIFERATION; DOWN-REGULATION; FORKHEAD TRANSCRIPTION FACTORS; FUSION PROTEINS, BCR-ABL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PROTEIN KINASE INHIBITORS; STEM CELLS; TUMOR CELLS, CULTURED;

EID: 77949894226     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M109.075788     Document Type: Erratum

References (0)